FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2000648487> ?p ?o ?g. }

• W2000648487 endingPage "977" @default.
• W2000648487 startingPage "971" @default.
• W2000648487 abstract "Background Obstructive sleep apnea (OSA) is a highly prevalent disorder that has been associated with an increased risk for cardiovascular morbidity, even in children. However, not all children with OSA manifest alterations in endothelial postocclusive hyperemia, an endothelial nitric oxide synthase (eNOS)-dependent response. Since expression of the eNOS gene is regulated by epigenetic mechanisms and OSA may cause epigenetic modifications such as DNA hypermethylation, we hypothesized that epigenetic modifications in the eNOS gene may underlie the differential vascular phenotypes in pediatric OSA. Methods Age-, sex-, ethnicity-, and BMI-matched prepubertal children with polysomnographically confirmed OSA and either normal (OSAn) or abnormal (OSAab) postocclusive hyperemic responses, assessed as the time to attain peak reperfusion flow (Tmax) by laser Doppler flowmetry, were recruited. Blood genomic DNA was assessed for epigenetic modifications in the eNOS gene using pyrosequencing. Children with no evidence of OSA or endothelial dysfunction served as a control group. Results The study comprised 36 children with OSA (11 with OSAab and 25 with OSAn) and 35 children in the control group. Overall, the mean age was 7.5 ± 2.4 years, 65% were boys, and 30% were obese; mean apnea-hypopnea index was 18 ± 8.6/h of sleep for the children with OSA. Tmax was 66.7 ± 8.8 s in the OSAab group and 30.1 ± 8.3 s in the OSAn group (P < .001). Pyrosequencing of the proximal promoter region of the eNOS gene revealed no significant differences in six of the seven CpG sites. However, a CpG site located at position −171 (relative to transcription start site), approximating important transcriptional elements, displayed significantly higher methylation levels in the OSAab group as compared with the OSAn or control groups (81.5% ± 3.5%, 74.8% ± 1.4%, and 74.5% ± 1.7%, respectively; P < .001). eNOS mRNA expression levels were assessed in a separate group of children and were significantly reduced in the OSAab group in comparison with the OSAn group. Conclusions The presence of abnormal eNOS-dependent vascular responses in children with OSA is associated with epigenetic modifications in the eNOS gene. Obstructive sleep apnea (OSA) is a highly prevalent disorder that has been associated with an increased risk for cardiovascular morbidity, even in children. However, not all children with OSA manifest alterations in endothelial postocclusive hyperemia, an endothelial nitric oxide synthase (eNOS)-dependent response. Since expression of the eNOS gene is regulated by epigenetic mechanisms and OSA may cause epigenetic modifications such as DNA hypermethylation, we hypothesized that epigenetic modifications in the eNOS gene may underlie the differential vascular phenotypes in pediatric OSA. Age-, sex-, ethnicity-, and BMI-matched prepubertal children with polysomnographically confirmed OSA and either normal (OSAn) or abnormal (OSAab) postocclusive hyperemic responses, assessed as the time to attain peak reperfusion flow (Tmax) by laser Doppler flowmetry, were recruited. Blood genomic DNA was assessed for epigenetic modifications in the eNOS gene using pyrosequencing. Children with no evidence of OSA or endothelial dysfunction served as a control group. The study comprised 36 children with OSA (11 with OSAab and 25 with OSAn) and 35 children in the control group. Overall, the mean age was 7.5 ± 2.4 years, 65% were boys, and 30% were obese; mean apnea-hypopnea index was 18 ± 8.6/h of sleep for the children with OSA. Tmax was 66.7 ± 8.8 s in the OSAab group and 30.1 ± 8.3 s in the OSAn group (P < .001). Pyrosequencing of the proximal promoter region of the eNOS gene revealed no significant differences in six of the seven CpG sites. However, a CpG site located at position −171 (relative to transcription start site), approximating important transcriptional elements, displayed significantly higher methylation levels in the OSAab group as compared with the OSAn or control groups (81.5% ± 3.5%, 74.8% ± 1.4%, and 74.5% ± 1.7%, respectively; P < .001). eNOS mRNA expression levels were assessed in a separate group of children and were significantly reduced in the OSAab group in comparison with the OSAn group. The presence of abnormal eNOS-dependent vascular responses in children with OSA is associated with epigenetic modifications in the eNOS gene." @default.
• W2000648487 created "2016-06-24" @default.
• W2000648487 creator A5003642180 @default.
• W2000648487 creator A5038079734 @default.
• W2000648487 creator A5043623030 @default.
• W2000648487 creator A5058447595 @default.
• W2000648487 creator A5081821354 @default.
• W2000648487 date "2013-04-01" @default.
• W2000648487 modified "2023-10-17" @default.
• W2000648487 title "Endothelial Dysfunction in Children With Obstructive Sleep Apnea Is Associated With Epigenetic Changes in the eNOS Gene" @default.
• W2000648487 cites W1519102962 @default.
• W2000648487 cites W1546150314 @default.
• W2000648487 cites W1965219852 @default.
• W2000648487 cites W1969599461 @default.
• W2000648487 cites W1973294362 @default.
• W2000648487 cites W1987932410 @default.
• W2000648487 cites W1988456052 @default.
• W2000648487 cites W1996076242 @default.
• W2000648487 cites W2000619215 @default.
• W2000648487 cites W2029339316 @default.
• W2000648487 cites W2040296083 @default.
• W2000648487 cites W2043868350 @default.
• W2000648487 cites W2074326406 @default.
• W2000648487 cites W2083977776 @default.
• W2000648487 cites W2092597346 @default.
• W2000648487 cites W2099343472 @default.
• W2000648487 cites W2099959716 @default.
• W2000648487 cites W2104346861 @default.
• W2000648487 cites W2106694682 @default.
• W2000648487 cites W2107953003 @default.
• W2000648487 cites W2110938570 @default.
• W2000648487 cites W2120572713 @default.
• W2000648487 cites W2120662805 @default.
• W2000648487 cites W2122250382 @default.
• W2000648487 cites W2122948975 @default.
• W2000648487 cites W2123914057 @default.
• W2000648487 cites W2125293265 @default.
• W2000648487 cites W2133628901 @default.
• W2000648487 cites W2139356364 @default.
• W2000648487 cites W2146062521 @default.
• W2000648487 cites W2147360810 @default.
• W2000648487 cites W2148081915 @default.
• W2000648487 cites W2157223254 @default.
• W2000648487 cites W2158733959 @default.
• W2000648487 cites W2166977140 @default.
• W2000648487 cites W2169808775 @default.
• W2000648487 cites W2471195096 @default.
• W2000648487 doi "https://doi.org/10.1378/chest.12-2026" @default.
• W2000648487 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3616686" @default.
• W2000648487 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23328840" @default.
• W2000648487 hasPublicationYear "2013" @default.
• W2000648487 type Work @default.
• W2000648487 sameAs 2000648487 @default.
• W2000648487 citedByCount "66" @default.
• W2000648487 countsByYear W20006484872013 @default.
• W2000648487 countsByYear W20006484872014 @default.
• W2000648487 countsByYear W20006484872015 @default.
• W2000648487 countsByYear W20006484872016 @default.
• W2000648487 countsByYear W20006484872017 @default.
• W2000648487 countsByYear W20006484872018 @default.
• W2000648487 countsByYear W20006484872019 @default.
• W2000648487 countsByYear W20006484872020 @default.
• W2000648487 countsByYear W20006484872021 @default.
• W2000648487 countsByYear W20006484872022 @default.
• W2000648487 countsByYear W20006484872023 @default.
• W2000648487 crossrefType "journal-article" @default.
• W2000648487 hasAuthorship W2000648487A5003642180 @default.
• W2000648487 hasAuthorship W2000648487A5038079734 @default.
• W2000648487 hasAuthorship W2000648487A5043623030 @default.
• W2000648487 hasAuthorship W2000648487A5058447595 @default.
• W2000648487 hasAuthorship W2000648487A5081821354 @default.
• W2000648487 hasBestOaLocation W20006484872 @default.
• W2000648487 hasConcept C104317684 @default.
• W2000648487 hasConcept C126322002 @default.
• W2000648487 hasConcept C134018914 @default.
• W2000648487 hasConcept C150194340 @default.
• W2000648487 hasConcept C164705383 @default.
• W2000648487 hasConcept C190727270 @default.
• W2000648487 hasConcept C2776006263 @default.
• W2000648487 hasConcept C2777622882 @default.
• W2000648487 hasConcept C2778326061 @default.
• W2000648487 hasConcept C2780972559 @default.
• W2000648487 hasConcept C41091548 @default.
• W2000648487 hasConcept C519581460 @default.
• W2000648487 hasConcept C54355233 @default.
• W2000648487 hasConcept C71924100 @default.
• W2000648487 hasConcept C86803240 @default.
• W2000648487 hasConceptScore W2000648487C104317684 @default.
• W2000648487 hasConceptScore W2000648487C126322002 @default.
• W2000648487 hasConceptScore W2000648487C134018914 @default.
• W2000648487 hasConceptScore W2000648487C150194340 @default.
• W2000648487 hasConceptScore W2000648487C164705383 @default.
• W2000648487 hasConceptScore W2000648487C190727270 @default.
• W2000648487 hasConceptScore W2000648487C2776006263 @default.
• W2000648487 hasConceptScore W2000648487C2777622882 @default.
• W2000648487 hasConceptScore W2000648487C2778326061 @default.
• W2000648487 hasConceptScore W2000648487C2780972559 @default.
• W2000648487 hasConceptScore W2000648487C41091548 @default.

• next